Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Drug Manufacturers
Shilpa Medicare Ltd (BOM:530549) Q2 FY25 Earnings Call Highlights: Strong Formulations Drive Revenue Growth Amid API Challenges
Shilpa Medicare Ltd (BOM:530549) reports robust revenue and EBITDA growth, while addressing challenges in the API segment and high tax rates. Nov 15, 2024
GuruFocus News Drug Manufacturers
Ipca Laboratories Ltd (BOM:524494) Q2 2025 Earnings Call Highlights: Strong Growth in Domestic and Export Formulations
Ipca Laboratories Ltd (BOM:524494) reports robust growth in key segments, despite challenges in branded promotional and API businesses. Nov 15, 2024
GuruFocus News Drug Manufacturers
Sequent Scientific Ltd (BOM:512529) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Merger Impact
Sequent Scientific Ltd (BOM:512529) reports robust revenue growth and transformative merger benefits, despite challenges in API revenues and geopolitical risks. Nov 15, 2024